United States Deep Vein Thrombosis Interventions Landscape Report 2022: Focus on Interventional Radiologists and Vascular Surgeons
13 oct. 2022 04h28 HE
|
Research and Markets
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "The United States Deep Vein Thrombosis Interventions Landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future...
Anthos Therapeutics Launches Second Phase 3 Clinical Trial of Its Dual-acting Factor XI Inhibitor, Abelacimab
25 août 2022 08h00 HE
|
Anthos Therapeutics
Abelacimab is the only Factor XI inhibitor currently being evaluated in Phase 3 trials The MAGNOLIA study will compare abelacimab against the current standard of care for VTE in cancer associated...
Worldwide Varicose Vein Treatments Industry to 2026 - Impact of Demographic, Economic, and Other Factors That Will Drive Future Demand
14 mai 2021 05h03 HE
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Global Varicose Vein Treatments Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. Varicose veins treatment includes...
Amaranth Medical Completes MEND-II and RENASCENT Studies and Initiates Study of 120-Micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
15 oct. 2015 08h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 15, 2015 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced that enrollment has successfully concluded in its multi-center, international...
Amaranth Medical Reports Positive Safety and Feasibility Findings for the FORTITUDE(TM) Bioresorbable Scaffold
28 oct. 2013 08h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Oct. 28, 2013 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company,
presented positive six-month angiographic results from its
first-in-human study...
![American Heart Association Logo](/news-release/logo/213500/0/213500.jpg?lastModified=12%2F09%2F2016%2022%3A55%3A27&size=2)
Dr. Alan Daugherty Named Editor of ATVB Journal
02 juil. 2012 13h01 HE
|
American Heart Association
DALLAS, July 2, 2012 (GLOBE NEWSWIRE) -- The American Heart Association and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, are pleased to announce the appointment of Alan...